Coeptis Therapeutics Stock Forum

$Coeptis Therapeutics (COEP.US)$
Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
1 minute ago, 5:15 AM PST
Via PR Newswire
The Acquisition of NexGenAI Affiliates Network Expands Company's Capabilities and Drives Innovation, Operational Efficiency, and Opportunity for Growth
WEXFORD, Pa. , Dec. 3, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"...

$Coeptis Therapeutics (COEP.US)$ Press Release: Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
Dow Jones· just

$Coeptis Therapeutics (COEP.US)$ Reuters· just
Coeptis Therapeutics Announces Phase 1 Data on Dvx201 for Covid-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

$Coeptis Therapeutics (COEP.US)$
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Developmen
Coeptis Therapeutics announced the acceptance of Phase 1 study results for DVX201, an allogeneic natural killer (NK) cell therapy, in Molecular Therapy Methods and Clinical Development. The study evaluated DVX201 for treating hospitalized COVID-19 patients at high risk for disease progression. Key f...

$Coeptis Therapeutics (COEP.US)$
Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use
Coeptis Therapeutics Holdings (Nasdaq: COEP) has expanded its license agreement with Deverra Therapeutics to include pandemic preparedness and emergency use applications for their allogeneic natural killer (NK) cell technology. The expanded license now covers the use of unmodified NK cells for treating viral infections, pandemic-related illnesses, ...

$Coeptis Therapeutics (COEP.US)$ Reuters· just
Coeptis Therapeutics Expands License Agreement With Deverra to Include Pandemic Preparedness, and Emergency

$Coeptis Therapeutics (COEP.US)$I think this has finally hit ROCK bottom after an everylasting free fall. I think this broke company will finally pump a little. Remember they must hold $1 to meet Nasdaq’s requirement. But they can also just delist after some period.. They just dont have the funds for financial stability..

$Coeptis Therapeutics (COEP.US)$ Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
3 MINUTES AGO, 7:07 AM EDT
VIA PR NEWSWIRE